Gammaked
Administration: IVIG or SCIG
Concentration: 10% (100 mg/mL)
Approved for: Ages 2+
Report side effects/adverse reactions at 1-855-353-7466 or https://www.kedrion.us/ pharmacovigilance/.
Gammagard Liquid ERC
Administration: IVIG or SCIG
Concentration: 10% (100 mg/mL)
Approved for: Ages 2+
Report side effects/adverse reactions at pvsafetyamericas@takeda.com or 1-877-825-3327.
Gammagard S/D
NOTE: Takeda is discontinuing Gammagard S/D in December 2027.
Administration: IVIG
Concentration: 5% (50 mg/mL) or 10% (100 mg/mL)
Approved for: Ages 2+
Report side effects/adverse reactions at pvsafetyamericas@takeda.com or 1-877-825-3327.
Gammagard Liquid
Administration: IVIG or SCIG
Concentration: 10% (100 mg/mL)
Approved for: Ages 2+
Report side effects/adverse reactions at pvsafetyamericas@takeda.com or 1-877-825-3327.
Flebogamma DIF
Administration: IVIG
Concentration: 5% (50 mg/mL) or 10% (100 mg/mL)
Approved for: Ages 2+
Report side effects/adverse reactions at https://www.grifols.com/en/notification-of-adverse-reaction.
Cuvitru
Administration: SCIG
Concentration: 20% (200 mg/mL)
Approved for: Ages 2+
Report side effects/adverse reactions at pvsafetyamericas@takeda.com or 1-877-825-3327.
Cutaquig
Administration: SCIG
Concentration: 16.5% (165 mg/mL)
Approved for: Ages 2+
Octapharma and Pfizer both distribute Cutaquig. Each company has its own product website and may have its own copay assistance program. If your infusion center or hospital supplies Cutaquig, it is typically distributed by Octapharma. If you get Cutaquig through a specialty pharmacy/for home care, it is distributed by Pfizer.
Report side effects/adverse reactions at 201-604-1137.
Biotest AG
Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and biotherapeutic drugs.
Kedrion
At Kedrion Biopharma, our mission is to enhance lives through our work in the field of rare and ultra-rare diseases. We are committed to collecting plasma and producing plasma-derived therapies that treat and prevent rare and debilitating conditions such as Coagulation and Neurological Disorders, Immunodeficiencies, and Rh sensitization.
Fondazione Telethon ETS
Fondazione Telethon is an Italian non-profit organization committed to advancing research on rare genetic diseases. For over 35 years, we have supported high-impact science aimed at developing innovative treatments and improving the lives of people affected by these conditions.
